Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 4 1

Status

Completed 77Unknown 21Terminated 10Active not recruiting 4Recruiting 3Suspended 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Gastrointestinal 2Head & Neck 1

Conditions

Colorectal Neoplasms 56Stomach Neoplasms 27Pancreatic Neoplasms 18Rectal Neoplasms 16Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Neoplasm Metastasis 11Esophageal Squamous Cell Carcinoma 8Esophageal Neoplasms 8Colonic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Hepatocellular 8Adenocarcinoma 8Head and Neck Neoplasms 7Gastrointestinal Neoplasms 7Biliary Tract Neoplasms 6Adenocarcinoma Of Esophagus 6Ovarian Neoplasms 5Peritoneal Neoplasms 4Advanced Solid Tumors 4Urinary Bladder Neoplasms 3Nasopharyngeal Carcinoma 3Lung Neoplasms 3Endometrial Neoplasms 3Cholangiocarcinoma 3Carcinoma, Transitional Cell 3Carcinoma 3Breast Neoplasms 3Appendiceal Neoplasms 3Locally Recurrent Rectal Cancer 2

Interventions

Fulvestrant 58Trastuzumab 49Capecitabine 48Letrozole 45pembrolizumab 41Carboplatin 41Paclitaxel 39Cyclophosphamide 38ribociclib 37pertuzumab 36abemaciclib 36Blood Specimen Collection 31Specimen Handling 28trastuzumab deruxtecan 27Docetaxel 27Surveys and Questionnaires 26Anastrozole 25exemestane 24Tamoxifen 24palbociclib 21130-nm albumin-bound paclitaxel 21Magnetic Resonance Spectroscopy 20Biopsy 19sacituzumab govitecan 18eribulin 18Radiotherapy 18Gemcitabine 18olaparib 17Injections 17Epirubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms × Fluorouracil × Clear all
NCT07318805 2026-05-08

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

Pfizer

Phase 1 Recruiting
260 enrolled
BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT07158164 2025-11-13

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Rutgers, The State University of New Jersey

Phase 4 Recruiting
100 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Colorectal Neoplasms

NCT02897700 2024-04-17

COC-IDCB

Shanghai Jiao Tong University School of Medicine

Phase 1 Recruiting
300 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡